PRESS ROOM

Media

Press coverage, founder milestones, and innovation updates
from Soin Pharmaceuticals.

Overview

Soin Pharmaceuticals has been featured in media coverage focused on healthcare innovation, founder entrepreneurship, and next-generation drug delivery. This page brings together public coverage, project highlights, and company updates in one place.

Press

Featured coverage

Additional outlets will be listed here once final URLs, titles, and any pull quotes are confirmed.

GeekWire

IBTimes

Founder proof points

Milestones

01

Cofounded by Aviraj, Dhilen, and Brijen Soin

02

Public coverage of Oral Thin Filament platform development

03

Founder participation in research and abstract-based medical work

04

Expansion of innovation story into AI-enabled healthcare tools

Assets

Media kit

Founder bios

Short and long-form bios for Aviraj, Dhilen & Brijen Soin, covering their entrepreneurship and research background.

PDF · 240 KB

Approved headshots

Press-ready founder photography in high resolution, cleared for editorial use.

ZIP · 8.4 MB

Company boilerplate

Standard short and long company descriptions for use in press articles.

TXT · 4 KB

Logo files

Primary wordmark, monogram, and light/dark variants in vector and raster format.

SVG / PNG · 1.2 MB

Platform language

Approved Oral Thin Filament terminology and product- platform phrasing.

PDF · 180 KB

Press contact

Direct channel for media enquiries, interviews, and fact- checking requests.

Email · press@soinpharma.com

Boilerplate

Soin Pharmaceuticals is a founder-led healthcare innovation company focused on Oral Thin Filament technology and patient-centered product concepts across allergy, pain control, wellness support, and AI-enabled healthcare research.